全文获取类型
收费全文 | 23582篇 |
免费 | 1718篇 |
国内免费 | 88篇 |
专业分类
耳鼻咽喉 | 200篇 |
儿科学 | 646篇 |
妇产科学 | 556篇 |
基础医学 | 2782篇 |
口腔科学 | 494篇 |
临床医学 | 2578篇 |
内科学 | 4526篇 |
皮肤病学 | 222篇 |
神经病学 | 2467篇 |
特种医学 | 819篇 |
外国民族医学 | 3篇 |
外科学 | 3701篇 |
综合类 | 337篇 |
一般理论 | 18篇 |
预防医学 | 2043篇 |
眼科学 | 580篇 |
药学 | 1744篇 |
中国医学 | 15篇 |
肿瘤学 | 1657篇 |
出版年
2023年 | 100篇 |
2022年 | 181篇 |
2021年 | 372篇 |
2020年 | 248篇 |
2019年 | 395篇 |
2018年 | 493篇 |
2017年 | 353篇 |
2016年 | 398篇 |
2015年 | 456篇 |
2014年 | 657篇 |
2013年 | 1006篇 |
2012年 | 1533篇 |
2011年 | 1591篇 |
2010年 | 909篇 |
2009年 | 747篇 |
2008年 | 1500篇 |
2007年 | 1687篇 |
2006年 | 1494篇 |
2005年 | 1487篇 |
2004年 | 1541篇 |
2003年 | 1364篇 |
2002年 | 1346篇 |
2001年 | 305篇 |
2000年 | 272篇 |
1999年 | 293篇 |
1998年 | 313篇 |
1997年 | 276篇 |
1996年 | 224篇 |
1995年 | 191篇 |
1994年 | 187篇 |
1993年 | 176篇 |
1992年 | 231篇 |
1991年 | 205篇 |
1990年 | 200篇 |
1989年 | 164篇 |
1988年 | 179篇 |
1987年 | 154篇 |
1986年 | 158篇 |
1985年 | 126篇 |
1984年 | 138篇 |
1983年 | 146篇 |
1982年 | 119篇 |
1981年 | 130篇 |
1980年 | 99篇 |
1979年 | 105篇 |
1978年 | 98篇 |
1976年 | 100篇 |
1975年 | 99篇 |
1974年 | 102篇 |
1973年 | 94篇 |
排序方式: 共有10000条查询结果,搜索用时 8 毫秒
1.
2.
3.
The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing 总被引:1,自引:0,他引:1
Kevin Conway MRCS ; Patricia Price PhD ; Keith G. Harding FRCS ; Wen G. Jiang MD 《Wound repair and regeneration》2006,14(1):2-10
Wound healing involves a number of cellular and molecular events, many of which are controlled by soluble growth factors. In the process of healing, hepatocyte growth factor, a cytokine known to act as mitogen, motogen, and morphogen, has been postulated to play multiple roles during several stages of this complex biological process. Produced primarily by stromal fibroblasts, hepatocyte growth factor regulates angiogenesis, vascular permeability, cell migration, matrix deposition and degradation, and other biological processes. The current article discusses recent progress in understanding the multiple roles played by this growth factor in tissue repair. 相似文献
4.
5.
6.
The intent of this study was to determine whether chronic ethanol (EtOH) vapor inhalation, with or without adjunct pyrazole (PYR) administration, was stressful in mice, as defined by increases in plasma corticosterone (CORT) concentration. Mice were randomly assigned to groups differentiated both on the basis of EtOH vapor exposure and the presence or absence of PYR administration. Blood samples for blood EtOH concentration (BEC) and plasma CORT concentration were obtained from mice after 72-96 hours of treatment. Mice were sacrificed after 96 hours of treatment and body and adrenal weight determined. BEC was significantly higher in PYR-treated animals and animals treated with the higher EtOH vapor concentration. Plasma CORT was elevated in proportion to BEC; however, other nonspecific stresses, in particular that of PYR administration, also elevated plasma CORT. Nonspecific stresses associated with this protocol may reduce the generality of these observations. Nevertheless, the high correlation between BEC and plasma CORT concentration in the PYR groups indicates that, with suitable control groups, the PYR-EtOH vapor inhalation approach is viable for studies concerned with EtOH effects on hypothalamic-anterior pituitary-adrenocortical function. 相似文献
7.
Primary extraosseous osteogenic sarcoma of the mediastinum: clinical, pathologic, and radiologic correlation 总被引:1,自引:0,他引:1
R W Tarr T Kerner B McCook D L Page E P Nance J J Kaye 《Southern medical journal》1988,81(10):1317-1319
We have presented a rare case of primary involvement of the anterior mediastinum by osteogenic sarcoma in which CT was useful in demonstrating calcium within the mass, and in distinguishing the mass from surrounding bony structures. Although rare, extraosseous osteogenic sarcoma should be included in the differential diagnosis of a calcified anterior mediastinal mass. 相似文献
8.
9.
RenNew-D (Alcide), a novel demand-release sporocidal agent, was employed instead of formaldehyde in the reprocessing for reuse of cuprophan hollow fiber dialyzers (Gambro) and the performance of these dialyzers was evaluated over 40 consecutive dialyses in six patients on maintenance hemodialysis. When RenNew-D was part of automated reprocessing performed with 4.3% bleach as specified by the manufacturer (Lixivitron), dialyzer survival was prolonged (16.7 +/- 7.2 uses) and hemodialysis neutropenia was unchanged with reuse. When RenNew-D was part of manual reprocessing conducted in the absence of bleach, marked improvement in dialyzer biocompatibility was observed but with a decreased survival (4.8 +/- 3.0). The majority of dialyzer failures were due to a fall in fiber bundle volume below a 85% set limit. Small solute clearances were maintained with both types of reprocessing. Dialyses were well tolerated throughout. Our data suggest that RenNew-D is a safe and efficacious product which can serve as a valuable alternative to formaldehyde for the purpose of dialyzer reuse. 相似文献